Bryan Stuart
2023
In 2023, Bryan Stuart earned a total compensation of $1.9M as Former President and Chief Executive Officer at Fulcrum Therapeutics, a 53% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,294,861 |
|---|---|
| Salary | $2,385 |
| Other | $572,450 |
| Total | $1,869,696 |
Stuart received $1.3M in option awards, accounting for 69% of the total pay in 2023.
Stuart also received $2.4K in salary and $572.5K in other compensation.
Rankings
In 2023, Bryan Stuart's compensation ranked 575th out of 2,907 executives tracked by ExecPay. In other words, Stuart earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 575 out of 2,907 | 80th |
Division Manufacturing | 330 out of 1,599 | 79th |
Major group Chemicals And Allied Products | 229 out of 901 | 75th |
Industry group Drugs | 226 out of 864 | 74th |
Industry Pharmaceutical Preparations | 142 out of 622 | 77th |
Source: SEC filing on April 19, 2024.
Stuart's colleagues
We found five more compensation records of executives who worked with Bryan Stuart at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Robert Gould
Fulcrum Therapeutics